Åpent møte


mars 2022

Is USA your next market?

Then learning and planning is key! Join the introductory webinar for the cross-cluster project “USA Next”, and learn more about how your company can benefit.

The US is the largest health market in the world, and possibly the hardest. Going into this market should be based on strategy and knowledge. Through “USA Next” you will learn about regulatory and reimbursement, the US health system, market dynamics, get introduced to experts – basically making a roadmap to the US market.

Time: 14.30 - 16.00

This introductory webinar will give you the first glance at what to expect from the project and the process. We hope you will join us and meet, discuss, and be inspired by US and Norwegian experts. Register now and invest the time into your future – or current – US market entry strategy!

The webinar is useful for Norwegian SMEs (start-ups, biotech, medtech and tech companies) planning to initiate or expand their activities towards the US (e.g. R&D partnerships, clinical development, licensing and deal-making, regulatory framework and advice, reimbursement structures and strategies, market access, attracting US Investment)

The program:

  • 14:30 – 14:45 Welcome and Introduction: What is USA Next & how can you benefit? Introduction from the four clusters and VIKEN
  • 14:45 – 15:05 A Roadmap to the US: Where, When and How? Peter Bak, Managing Director, Back Bay Life Science Advisors (BBLSA), Boston, USA
  • 15:05 – 15:20 Insights & Lessons Learned: Two Industry Experts Sharing Learnings Along the Way:
    • Kari Krogstad; CEO and President Medistim (TBC)
    • Richard Godfrey; COO LifeArc, London, UK; Senior Executive Consultant & Board Member Gnist Executive Consultants, Norway, Former CEO of BergenBio
  • 15:20 – 15:35 Panel incl. Q&A from the Audience
  • 15:35 – 15:45 Polls and open input session to collect feedback regarding topics for Trainings, Workshops offered by USA Next
  • 15:45 Closing and next steps

Prosjektet er støttet av Viken Fylkeskommune og programmet leveres i samarbeid med Innovasjon Norge: